Asthma affects 2 out of 10 people in Scotland and this chronic, variable, inflammatory disease is characterised by asthma attacks and symptoms including breathlessness and wheezing. [7] 'Mild' asthma ...

London, UK, Thursday 23 March 2023 – AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing ...

Pulmicort (budesonide) can cause common side effects such as nasal issues, sore throat, runny nose, and nausea. Specific side effects vary between the Flexhaler and Respules forms. Serious side ...

Please provide your email address to receive an email when new articles are posted on . GlaxoSmithKline and Innoviva’s triple-combination therapy of fluticasone furoate, umeclidinium and vilanterol ...

3.1 ICSs suppress inflammation in the lungs and are recommended for prophylactic treatment of asthma. In the UK, three ICSs are licensed for use in children: beclometasone dipropionate, budesonide and ...

This benefit of treatment with closed triple therapy was also observed in the subset of patients who received treatment for up to 52 weeks, with a statistically significant improvement of 179mL in ...

I am 4 weeks pregnant and no-one is really sure if my asthma medication is safe. I use Pulmicort Turbohaler irregularly and Ventheze pump quite often. My asthma is triggered by allergies etc. I have 3 ...

GlaxoSmithKline plc and Innoviva, Inc. announced the presentation of further data from the pivotal phase III FULFIL study with investigational closed triple ...